Description

Mc-Val-Cit-PAB-Gefitinib chloride is a agent-linker conjugates for ADC. Mc-Val-Cit-PAB-Gefitinib chloride consists of Gefitinib (HY-50895) (an EGFR tyrosine kinase inhibitor) and the ADC linker Mc-Val-Cit-PAB[1].–20°C (Powder, sealed storage, away from moisture and light)-Applications-Cancer-Kinase/protease-Formula-C50H63Cl2FN10O9-Citation–References-[1]FLYGARE, John A, et al. Quaternary amine compounds and antibody-drug conjugates thereof. WO2016090050A1. -CASNumber–MolecularWeight-1038.00-Compound Purity-98.69-SMILES-COC1=CC2=C(C=C1OCCCN3CCOCC3)C(NC(C=C4)=CC(Cl)=C4F)=NC=[N+]2CC(C=C5)=CC=C5NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCCCCN(C6=O)C(C=C6)=O)=O)=O)=O.[Cl-]-Research_Area-Cancer-Solubility-10 mM in DMSO-Target-Drug-Linker Conjugates for ADC-Isoform–Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related